Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 2CNS 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Leukemia 9Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Drug-Related Side Effects and Adverse Reactions 4Waldenstrom Macroglobulinemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Blast Crisis 3Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Prolymphocytic 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Hairy Cell 2Leukemia, Erythroblastic, Acute 2

Interventions

Cyclophosphamide 8Flow Cytometry 6Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Busulfan 4Antilymphocyte Serum 4Radiotherapy 3Polymerase Chain Reaction 3Immunologic Techniques 3Filgrastim 3Caspofungin 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3venetoclax 2thymoglobulin 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Voriconazole 2Thiotepa 2Thalidomide 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Nivolumab 2Itraconazole 2Ipilimumab 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Amifostine × Other hematologic neoplasm × Clear all
NCT00003425 2013-04-26

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

University of Kentucky

Phase 1/2 Completed
25 enrolled
BreastCNSGynecologicLymphoidOther hematologic neoplasmPlasma cellSarcoma

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡